SRRM2 and Alzheimer disease: Recent studies have linked nuclear speckle dysregulation to Alzheimer’s disease, with SRRM2 miss-localized to the cytoplasm of brain tissue in Alzheimer’s disease patients (McMillan et al., 2021).